Shares of Billiontoone, Inc. (NASDAQ:BLLN - Get Free Report) have been given a consensus recommendation of "Moderate Buy" by the ten research firms that are currently covering the stock, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell rating, three have given a hold rating and six have issued a buy rating on the company. The average 1 year target price among brokerages that have issued a report on the stock in the last year is $126.7143.
BLLN has been the subject of several recent analyst reports. JPMorgan Chase & Co. reduced their target price on shares of Billiontoone from $150.00 to $145.00 and set an "overweight" rating for the company in a research note on Wednesday, December 10th. BTIG Research dropped their price target on shares of Billiontoone from $160.00 to $140.00 and set a "buy" rating on the stock in a research note on Thursday, March 5th. Guggenheim reduced their price objective on shares of Billiontoone from $120.00 to $100.00 and set a "buy" rating for the company in a research report on Monday, March 30th. Wall Street Zen upgraded Billiontoone from a "hold" rating to a "buy" rating in a research report on Saturday, March 7th. Finally, Piper Sandler reissued an "overweight" rating on shares of Billiontoone in a research note on Wednesday, December 10th.
Read Our Latest Stock Report on BLLN
Billiontoone Stock Performance
NASDAQ:BLLN opened at $79.36 on Friday. The firm has a market capitalization of $3.65 billion and a price-to-earnings ratio of 377.90. The company has a debt-to-equity ratio of 0.12, a quick ratio of 11.32 and a current ratio of 11.69. The company has a 50 day moving average of $79.18. Billiontoone has a 12-month low of $61.96 and a 12-month high of $138.70.
Billiontoone (NASDAQ:BLLN - Get Free Report) last issued its quarterly earnings results on Wednesday, March 4th. The company reported $0.11 earnings per share for the quarter, topping the consensus estimate of $0.04 by $0.07. The company had revenue of $96.05 million for the quarter, compared to analyst estimates of $85.85 million. The firm's revenue was up 113.0% compared to the same quarter last year.
Institutional Inflows and Outflows
Several large investors have recently bought and sold shares of the business. Rossby Financial LCC acquired a new stake in Billiontoone in the fourth quarter valued at $25,000. Wells Fargo & Company MN purchased a new position in shares of Billiontoone in the 4th quarter valued at about $76,000. Smartleaf Asset Management LLC acquired a new stake in shares of Billiontoone in the fourth quarter valued at about $80,000. Nano Cap New Millennium Growth Fund L P purchased a new position in shares of Billiontoone during the 4th quarter worth approximately $82,000. Finally, Renaissance Capital LLC acquired a new position in Billiontoone in the 4th quarter valued at about $201,000.
Billiontoone Company Profile
(
Get Free Report)
BillionToOne NASDAQ: BLLN is a molecular diagnostics company that develops and commercializes high-precision genetic testing solutions based on single-molecule counting technology. The company’s platform is designed to detect and quantify rare genetic variants and chromosomal abnormalities from cell-free DNA, with a primary focus on applications in prenatal screening and other clinical genetic tests where sensitivity and specificity at very low allele fractions are critical.
BillionToOne’s offerings center on assay development and clinical testing workflows that enable non-invasive prenatal testing (NIPT) and targeted molecular diagnostics.
Read More
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Billiontoone, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Billiontoone wasn't on the list.
While Billiontoone currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
We are about to experience the greatest A.I. boom in stock market history...
Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.
That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.
- The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
- The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
- Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.
Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.
And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...
Simply click the link below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
